Belviq Tablet® Post Marketing Surveillance Protocol
Clinical trial NCT03741010 · UNKNOWN
Trial details
- NCT number
- NCT03741010
- Sponsor
- IlDong Pharmaceutical Co Ltd
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2015-02-02
- Primary completion
- 2021-02-01
- Enrollment
- 3000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.